Search

everythinglearnresearchcommunity

for

Search:↓

Gene variation affects prostate issues and hair loss.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

CD133+ cells are crucial for hair growth.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

CS12192 effectively treats alopecia areata with better safety than current options.

CD200 is not a reliable marker for identifying stem cells in all skin types.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

PDCD4 is important for controlling skin cell growth and healing.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

CD200- cells in hair follicles have a higher ability to regenerate hair.

The tool iCOUNT helps understand how stem cells divide and affect tissue development and repair.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Carbon dots from Cinnamomum burmannii leaves can promote hair growth and regeneration.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.